31 results
SC TO-C
EX-10.1
INVA
Innoviva Inc
11 Jul 22
Information about tender offer
3:46pm
, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter … genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties hereto agree that any rule of construction to the effect
SC TO-C
EX-2.1
INVA
Innoviva Inc
11 Jul 22
Information about tender offer
3:46pm
the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders … ; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties
8-K
EX-10.1
INVA
Innoviva Inc
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter … genders; and the neuter gender shall include masculine and feminine genders.
(b) The parties hereto agree that any rule of construction to the effect
8-K
EX-2.1
j2qldy6 a2ypsyvz
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
c99 13ujgikhadi2
11 Jul 22
Business combination disclosure
7:38am
SC TO-C
EX-2.1
9aup7zo21tc2swz
23 May 22
Information about tender offer
8:53pm
8-K
EX-2.1
cz2l xy7eljg
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-10.2
zfrp3
14 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.5
8gxj8edp ejirj4qdp
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
l0b36gnxp
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
zkrbjuf
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.3
5epj67u
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-4.4
jyk81z5l8 11hac8zstx
25 Jan 13
Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated Notes
12:00am
S-3ASR
EX-4.4
zcwjhmmlbg lpi
16 Jan 13
Automatic shelf registration
12:00am
8-K
EX-99.11
kaxjd ev8avr
4 Sep 12
Other Events
12:00am
8-K
EX-99.13
6nk5ef7 m7ar
4 Sep 12
Other Events
12:00am
8-K
EX-99.6
6ri m1qt1f3nzds96q
4 Sep 12
Other Events
12:00am